Flu News and Research

RSS

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

The pathogen that we are talking about is called streptococcus pneumoniae. That is a fairly common bacteria and if you did a nasal swab you would find that quite a lot of people have this bacterium living in their nasal passages.

16 Apr 2013

Published report describes 3 cases of H7N9; Researchers developing quick test, vaccine

A new report by a team of Chinese researchers describing the cases of three people who died of the H7N9 avian flu strain in China "was published Thursday in the New England Journal of Medicine along with a commentary from American health officials, who said the disease 'raises many urgent questions and global public health concerns,'" the New York Times reports.

15 Apr 2013

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

A genetic analysis of the avian flu virus responsible for at least nine human deaths in China portrays a virus evolving to adapt to human cells, raising concern about its potential to spark a new global flu pandemic.

15 Apr 2013

U.S., Chinese researchers developing vaccine for H7N9 avian flu virus; Some question speed of case reporting

"Less than two weeks after Chinese officials released the genetic sequence of a new type of bird flu [H7N9], U.S. vaccine experts are well on the way to making a vaccine to protect people against it," NBC News's "Vitals" blog reports (Fox, 4/10).

12 Apr 2013

Australian, Singapore researchers join hands to combat disease-causing bugs

The fight against a number of significant infectious diseases in the Asia-Pacific region has been given a boost through a new research collaboration between the National Health and Medical Research Council in Australia and the Agency for Science, Technology and Research in Singapore.

12 Apr 2013

China reports additional deaths from H7N9; Scientists work to uncover source

"China reported two more fatalities from a new strain of avian flu [H7N9] on Tuesday, bringing the death toll to nine, and raised the total number of infections by four to 28 as the government renewed efforts to combat the spread of the disease," the Wall Street Journal reports (Tejada/Burkitt, 4/9).

11 Apr 2013

Researchers evaluate Pexa-Vec to slow progression of liver cancer

As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.

10 Apr 2013

Recent articles from Journal of American College Health focus on campus safety

In a recent Editorial: How Safe Are College Campuses? published in the Journal of American College Health, Co-Editor Dr. Teri Aronowitz compares the frequency of violence in the USA to that of the flu.

10 Apr 2013

Research sheds light on malaria-related parasite's transition from acute to chronic stage

A new discovery about the malaria-related parasite Toxoplasma gondii -- which can threaten babies, AIDS patients, the elderly and others with weakened immune function -- may help solve the mystery of how this single-celled parasite establishes life-long infections in people.

10 Apr 2013

Patients follow preventive health practices if their doctors do likewise

Patients are more likely to follow preventive health practices like getting a flu shot or mammography if their doctors do likewise, researchers at the University of British Columbia and in Israel have discovered.

9 Apr 2013

Study: Chicken-killing virus is a promising treatment for prostate cancer

A study at the Virginia-Maryland Regional College of Veterinary Medicine has identified a chicken-killing virus as a promising treatment for prostate cancer in humans.

9 Apr 2013

Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that they will be presenting positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate "H5N1 vaccine" at the World Vaccine Congress.

9 Apr 2013

Research findings could help develop effective vaccines against new strains of bird flu

Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.

9 Apr 2013

WHO considers sending experts to China as death toll from H7N9 virus hits 7

The WHO "is talking with the Chinese government about sending international experts to China to help investigate a new bird flu strain that has sickened at least 24 people, killing seven of them," the Associated Press reports.

9 Apr 2013

Study finds positive link between physicians' preventive health practices and patients

There is a direct, positive link between physicians' preventive health practices and those of their patients, found a study published in CMAJ.

9 Apr 2013

National Jewish Health researchers unravel mystery of adjuvants

Aluminum salts, or alum, have been injected into billions of people as an adjuvant to make vaccines more effective.

8 Apr 2013

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

7 Apr 2013

Journalists, experts discuss China's response to H7N9 outbreak

In a conversation in the ChinaFile blog, David Wertime, co-founder and co-editor of Tea Leaf Nation, an English-language online magazine that analyzes Chinese social media, speaks with Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations; journalist Isabel Hilton; Donald Clarke, a professor at the George Washington University Law School in Washington, D.C.; Susan Jakes, editor of ChinaFile; Dorinda Elliott, editor at large at ChinaFile; and James Fallows, a correspondent for The Atlantic, about the emergence of a new strain of avian flu called H7N9 in China and the country's response to the outbreak so far.

6 Apr 2013

China begins slaughter of birds in Shanghai market after 6th death from H7N9 announced; U.S., global experts begin vaccine research

"China announced a sixth death from a new bird flu strain Friday, while authorities in Shanghai halted the sale of live fowl and slaughtered all poultry at a market where the virus was detected in pigeons being sold for meat," the Associated Press reports (Wong, 4/5).

6 Apr 2013

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

On Twitter, a popular microblogging and social-networking service, statements about vaccines may have unexpected effects -- positive messages may backfire, according to a team of Penn State University researchers led by Marcel Salath-, an assistant professor of biology.

5 Apr 2013

Flu News and Research

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Published report describes 3 cases of H7N9; Researchers developing quick test, vaccine

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

U.S., Chinese researchers developing vaccine for H7N9 avian flu virus; Some question speed of case reporting

Australian, Singapore researchers join hands to combat disease-causing bugs

China reports additional deaths from H7N9; Scientists work to uncover source

Researchers evaluate Pexa-Vec to slow progression of liver cancer

Recent articles from Journal of American College Health focus on campus safety

Research sheds light on malaria-related parasite's transition from acute to chronic stage

Patients follow preventive health practices if their doctors do likewise

Study: Chicken-killing virus is a promising treatment for prostate cancer

Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress

Research findings could help develop effective vaccines against new strains of bird flu

WHO considers sending experts to China as death toll from H7N9 virus hits 7

Study finds positive link between physicians' preventive health practices and patients

National Jewish Health researchers unravel mystery of adjuvants

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Journalists, experts discuss China's response to H7N9 outbreak

China begins slaughter of birds in Shanghai market after 6th death from H7N9 announced; U.S., global experts begin vaccine research

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News